ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,939, issued on Oct. 6, was assigned to QLARIS BIO INC. (Dedham, Mass.) and MAYO FOUNDTATION FOR MEDICAL EDUCATION AND RESEARCH (Rochester, Minn.).

"Topical ocular delivery of cromakalim" was invented by Thurein M. Htoo (Westwood, Mass.), Michael P. Fautsch (Rochester, Minn.), Gary Allred (Wake Forest, N.C.), Ralph Casale (Westford, Mass.) and Barbara M. Wirostko (Park City, Utah).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aqueous ocular topical pharmaceutical formulations are provided that deliver an effective amount of (lev)cromakalim or a pharmaceutically acceptable salt thereof to treat an anterior or a posterior ocular disorder that responds t...